Impact of use Tivortin on life quality and condition of the fetus in pregnant women with heart failure

А. Ю. Ліманська, Ю. В. Давидова, В. А. Слободський

Abstract


A study to examine the quality of life of the woman and the fetus in pregnant with heart failure as a result of the drug Tivortin use was performed.

There were examined 40 pregnant women with NYHA II–III heart failure on a background of cardiovascular disease and signs of fetal condition disorders. All patients received standard therapy of heart failure. Pregnant were divided into two groups of 20 women in each. In the main group to the basic therapy was additionally appointed arginine hydrochloride (drug Tivortin). The comparison group continued intake a basic therapy.

The results showed that the addition Tivortin to the basic treatment of pregnant women with heart failure improves quality of their life and overall health, and a significant improvement of the fetus in these women confirms the effectiveness of this therapy

Keywords


pregnancy; heart failure; nitric oxide; L-arginine; Tivortin

References


Babushkina A.V. «L-arginine in terms of evidence-based medicine.» Ukrainian Medical Journal, 6(2009):43-48.

Yelsky V.N., Vatutin N.T., Kalinkina N.V., Salakhova A.M. «Role of dysfunction edoteliya in the genesis of cardiovascular diseases.» Journal of Medical Sciences of Ukraine, 14(2008):51-62.

Slobodskoy V.A. «Role of L-arginine in the treatment of patients with cardiovascular disease.» Health of Ukraine, 13-14(2009):62.

Wheeler T., Evans P.W., Anthony F.W., Godfrey K.M., Howe D.T. and Osmond C. «Relationship between maternal serum vascular endothelial growth factor concentration in early pregnancy and fetal and placental growth.» Hum. Reprod., 14(2009):1619-1623.

Voronkov L.G., Paraschenyuk L.P., Lutsak E.A. «Quality of life in chronic heart failure: actual aspects.» Heart Failure, 3(2010):18-23.

Mendes de Leon C.F., Grady K.L., Eaton C. «Quality of life in a diverse population of heart failure patients.» J. Cardiopulm. Rehabil. Prev., 29(2009):171-178.


GOST Style Citations


1. Бабушкина А.В. L-аргинин с точки зрения доказательной медицины // Український медичний часопис. – 2009. – № 6. – С. 43–48.

2. Ельский В.Н., Ватутин Н.Т., Калинкина Н.В., Салахова А.М. Роль дисфункции эндотелия в генезе сердечно-сосудистых заболеваний // Журнал АМН Украины. – 2008. – № 14. – С. 51–62.

3. Слободской В.А. Роль L-аргинина в лечении пациентов с сердечно-сосудистой патологией // Здоровье Украины. – 2009. – № 13–14. – С. 62.

4. Wheeler T., Evans P.W., Anthony F.W., Godfrey K.M., Howe D.T. and Osmond C. «Relationship between maternal serum vascular endothelial growth factor concentration in early pregnancy and fetal and placental growth.» Hum. Reprod., 14(2009):1619-1623.

5. Воронков Л.Г., Паращенюк Л.П., Луцак Е.А. Качество жизни при хронической сердечной недостаточности: актуальные аспекты // Серцева недостатність. – 2010. – № 3. – C. 18–23.

6. Mendes de Leon C.F., Grady K.L., Eaton C. «Quality of life in a diverse population of heart failure patients.» J. Cardiopulm. Rehabil. Prev., 29(2009):171-178.





DOI: http://dx.doi.org/10.18370/2309-4117.2014.19.37-39

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)